Richard I Steinhart

BTAI

Richard I Steinhart serves as officer: Chief Financial Officer at BioXcel Therapeutics, Inc. (BTAI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$187.7K

Net Position

Net Seller

$187.7K

Companies Traded

BTAI

Active Period

Mar 2023 – May 2026

7 total trades

Most Recent

Sell BTAI

May 22, 2026 · $7.4K

Richard I Steinhart's Insider Trading at BioXcel Therapeutics, Inc. (BTAI)

Buys

0 · $0.00

Sells

7 · $187.7K

Total Shares Bought

Total Shares Sold

16,303

BTAI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 22, 2026	Sell	6,845	$1.08	$7.4K	26,300
Dec 14, 2024	Sell	577	$0.36	$206.98	0
Sep 14, 2024	Sell	356	$0.69	$245.60	0
Jun 14, 2024	Sell	372	$1.26	$469.54	0
Mar 14, 2024	Sell	1,069	$2.63	$2.8K	0
May 14, 2023	Sell	5,000	$27.17	$135.9K	0
Mar 14, 2023	Sell	2,084	$19.50	$40.6K	0

Related Insiders

Vimal Mehta

director, officer: CEO and President

BTAISell · May 22, 2026

Javier Rodriguez

officer: See Remarks

BTAISell · May 22, 2026

Frank Yocca

officer: Chief Scientific Officer

BTAISell · May 22, 2026

Explore More Insider Trading Data

BTAI Insider Trading Activity

View all insider trades at BioXcel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity